Number of Shares
57,361.00
Current Holdings Value*
$1.95 Mil
% of Portfolio
2.08%
Total Estimate Gain
$2.63 Mil
% of Total Estimate Gain
15.74%

Green Alpha Advisors, LLC's CRISPR Therapeutics AG Holding Summary

As of 2025-03-31, Green Alpha Advisors, LLC held 57,361.00 shares of CRISPR Therapeutics AG(CRSP), totaling $1.95 Mil. This investment constitutes 2.08% of their stock portfolio, and Green Alpha Advisors, LLC now holds 0.07% of the outstanding CRISPR Therapeutics AG(CRSP) stock.

The initial trade took place in 2020Q4. And since then Green Alpha Advisors, LLC has made 13 purchases of CRSP, at an average price of $60.37, for a total of 276,309.00 shares. In addition, there have been 4 sales at an average price of $71.11 for 218,948.00 shares. Based on historical transaction data and CRSP's current price of $65.13, Green Alpha Advisors, LLC's estimated gain on his CRSP holdings is $2.63 Mil, reflecting a 15.74% gain to date.

Green Alpha Advisors, LLC CRSP ($65.13) Holding Chart

Green Alpha Advisors, LLC CRSP ($65.13) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1